(-)-alpha-phellandrene increases expression ISO RGD:733932 6480464 alpha phellandrene results in increased expression of ENO2 mRNA CTD PMID:25075043 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane multiple interactions EXP 6480464 2 more ... CTD PMID:19414516 1,1-dichloroethene increases expression ISO RGD:10527 6480464 vinylidene chloride results in increased expression of ENO2 mRNA CTD PMID:26682919 1,10-phenanthroline increases expression ISO RGD:733932 6480464 1, 10-phenanthroline results in increased expression of ENO2 mRNA CTD PMID:19502547 1,2-dimethylhydrazine increases expression ISO RGD:10527 6480464 1, 2-Dimethylhydrazine results in increased expression of ENO2 mRNA CTD PMID:22206623 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine increases expression ISO RGD:10527 6480464 1-Methyl-4-phenyl-1 more ... CTD PMID:23562983 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine decreases expression ISO RGD:10527 6480464 1-Methyl-4-phenyl-1 more ... CTD PMID:30236862 17alpha-ethynylestradiol multiple interactions ISO RGD:10527 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ENO2 mRNA CTD PMID:17942748 17beta-estradiol decreases expression ISO RGD:733932 6480464 Estradiol results in decreased expression of ENO2 mRNA CTD PMID:15159206 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one decreases expression ISO RGD:733932 6480464 Metribolone results in decreased expression of ENO2 protein CTD PMID:17152098 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:10527 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:10527 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:10527 6480464 Tetrachlorodibenzodioxin affects the expression of ENO2 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:10527 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ENO2 mRNA CTD PMID:17942748 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO RGD:10527 6480464 2 more ... CTD PMID:16451863 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO RGD:733932 6480464 2 more ... CTD PMID:26705709 2-ethoxyethanol increases expression EXP 6480464 2-ethoxyethanol results in increased expression of ENO2 mRNA CTD PMID:19643169 2-hydroxypropanoic acid decreases expression ISO RGD:733932 6480464 Lactic Acid results in decreased expression of ENO2 mRNA CTD PMID:30851411 2-methoxyethanol increases expression EXP 6480464 methyl cellosolve results in increased expression of ENO2 mRNA CTD PMID:19643169 3',5'-cyclic AMP multiple interactions EXP 6480464 2 more ... CTD PMID:19414516 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:10527 6480464 tetrabromobisphenol A results in increased expression of ENO2 mRNA CTD PMID:25172293 3,4-dichloroaniline increases expression ISO RGD:733932 6480464 3, 4-dichloroaniline results in increased expression of ENO2 mRNA CTD PMID:24172598 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:733932 6480464 [Bucladesine co-treated with 1-Methyl-3-isobutylxanthine co-treated with EGF protein co-treated with FGF2 protein co-treated with NGF protein co-treated with BDNF protein] results in increased expression of ENO2 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of ENO2 mRNA CTD PMID:28628672 , PMID:29698629 3-methyladenine multiple interactions EXP 6480464 3-methyladenine inhibits the reaction [Sirolimus results in increased expression of ENO2 protein] CTD PMID:26676567 3-nitropropanoic acid decreases expression EXP 6480464 3-nitropropionic acid results in decreased expression of ENO2 mRNA CTD PMID:17672854 3-nitropropanoic acid multiple interactions EXP 6480464 Cannabidiol inhibits the reaction [3-nitropropionic acid results in decreased expression of ENO2 mRNA] CTD PMID:17672854 4,4'-sulfonyldiphenol decreases expression ISO RGD:733932 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of ENO2 mRNA CTD PMID:27685785 4,4'-sulfonyldiphenol increases expression ISO RGD:733932 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of ENO2 protein CTD PMID:34186270 4,4'-sulfonyldiphenol multiple interactions ISO RGD:733932 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of ENO2 mRNA CTD PMID:28628672 5-aza-2'-deoxycytidine affects expression ISO RGD:733932 6480464 Decitabine affects the expression of ENO2 mRNA CTD PMID:23300844 5-aza-2'-deoxycytidine multiple interactions ISO RGD:733932 6480464 [Decitabine co-treated with Vorinostat] affects the expression of ENO2 mRNA CTD PMID:17330099 5-azacytidine decreases expression ISO RGD:733932 6480464 Azacitidine results in decreased expression of ENO2 protein CTD PMID:20607034 acrylamide decreases expression ISO RGD:733932 6480464 Acrylamide results in decreased expression of ENO2 mRNA CTD PMID:32763439 aflatoxin B1 increases expression ISO RGD:733932 6480464 Aflatoxin B1 results in increased expression of ENO2 mRNA CTD PMID:27153756 aflatoxin B1 increases methylation ISO RGD:733932 6480464 Aflatoxin B1 results in increased methylation of ENO2 gene CTD PMID:27153756 aldehydo-D-glucose increases secretion ISO RGD:733932 6480464 Glucose deficiency results in increased secretion of ENO2 protein CTD PMID:24802182 all-trans-retinoic acid increases expression ISO RGD:733932 6480464 Tretinoin results in increased expression of ENO2 protein CTD PMID:16473924 all-trans-retinoic acid multiple interactions ISO RGD:10527 6480464 [perfluorooctane sulfonic acid co-treated with Tretinoin] results in decreased expression of ENO2 mRNA CTD PMID:23948355 alpha-phellandrene increases expression ISO RGD:733932 6480464 alpha phellandrene results in increased expression of ENO2 mRNA CTD PMID:25075043 aluminium atom decreases activity ISO RGD:733932 6480464 Aluminum results in decreased activity of ENO2 protein CTD PMID:11860913 aluminium(0) decreases activity ISO RGD:733932 6480464 Aluminum results in decreased activity of ENO2 protein CTD PMID:11860913 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of ENO2 mRNA CTD PMID:16483693 amphetamine multiple interactions ISO RGD:10527 6480464 Amphetamine inhibits the reaction [MDK gene mutant form results in decreased expression of ENO2 protein], Amphetamine inhibits the reaction [PTN gene mutant form results in decreased expression of ENO2 protein] CTD PMID:23459167 antirheumatic drug increases expression ISO RGD:733932 6480464 Antirheumatic Agents results in increased expression of ENO2 mRNA CTD PMID:24449571 aristolochic acid A decreases expression ISO RGD:733932 6480464 aristolochic acid I results in decreased expression of ENO2 mRNA CTD PMID:33212167 aristolochic acid A increases expression ISO RGD:733932 6480464 aristolochic acid I results in increased expression of ENO2 protein CTD PMID:33212167 aristolochic acids increases expression EXP 6480464 Aristolochic Acids results in increased expression of ENO2 mRNA CTD PMID:19717638 arsane multiple interactions ISO RGD:733932 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of ENO2 mRNA CTD PMID:32525701 arsenic atom multiple interactions ISO RGD:733932 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of ENO2 mRNA CTD PMID:32525701 arsenite(3-) increases expression ISO RGD:733932 6480464 arsenite results in increased expression of ENO2 mRNA, arsenite results in increased expression of ENO2 protein CTD PMID:22613180 Azaspiracid increases expression ISO RGD:733932 6480464 azaspiracid results in increased expression of ENO2 mRNA CTD PMID:28939011 azoxystrobin decreases expression ISO RGD:733932 6480464 azoxystrobin results in decreased expression of ENO2 mRNA CTD PMID:33512557 benzo[a]pyrene increases expression ISO RGD:10527 6480464 Benzo(a)pyrene results in increased expression of ENO2 mRNA, Benzo(a)pyrene results in increased expression of ENO2 protein CTD PMID:19449198 , PMID:22228805 benzo[a]pyrene increases expression ISO RGD:733932 6480464 Benzo(a)pyrene results in increased expression of ENO2 mRNA, Benzo(a)pyrene results in increased expression of ENO2 protein CTD PMID:32234424 , PMID:32717239 benzo[a]pyrene increases methylation ISO RGD:733932 6480464 Benzo(a)pyrene results in increased methylation of ENO2 promoter CTD PMID:27901495 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of ENO2 protein CTD PMID:21467743 benzo[a]pyrene multiple interactions ISO RGD:10527 6480464 Capsaicin inhibits the reaction [Benzo(a)pyrene results in increased expression of ENO2 protein] CTD PMID:19449198 benzo[a]pyrene diol epoxide I affects expression ISO RGD:733932 6480464 7 more ... CTD PMID:20382639 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:10527 6480464 Diethylhexyl Phthalate inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of ENO2 mRNA] CTD PMID:33484791 bisphenol A increases expression ISO RGD:10527 6480464 bisphenol A results in increased expression of ENO2 mRNA CTD PMID:23798566 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ENO2 mRNA CTD PMID:34947998 bisphenol A increases expression ISO RGD:733932 6480464 bisphenol A results in increased expression of ENO2 mRNA, bisphenol A results in increased expression of ENO2 protein CTD PMID:29275510 , PMID:34186270 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of ENO2 gene CTD PMID:28505145 bisphenol A decreases methylation ISO RGD:10527 6480464 bisphenol A results in decreased methylation of ENO2 promoter CTD PMID:27312807 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of ENO2 mRNA CTD PMID:25181051 bisphenol F decreases expression ISO RGD:10527 6480464 bisphenol F results in decreased expression of ENO2 mRNA CTD PMID:30951980 bleomycin A5 increases expression ISO RGD:733932 6480464 bleomycetin results in increased expression of ENO2 mRNA CTD PMID:21040473 bortezomib increases expression ISO RGD:733932 6480464 Bortezomib results in increased expression of ENO2 mRNA CTD PMID:20977926 bucladesine multiple interactions ISO RGD:733932 6480464 [Bucladesine co-treated with 1-Methyl-3-isobutylxanthine co-treated with EGF protein co-treated with FGF2 protein co-treated with NGF protein co-treated with BDNF protein] results in increased expression of ENO2 mRNA CTD PMID:29698629 butanal increases expression ISO RGD:733932 6480464 butyraldehyde results in increased expression of ENO2 mRNA CTD PMID:26079696 cadmium atom increases expression ISO RGD:733932 6480464 Cadmium results in increased expression of ENO2 mRNA, Cadmium results in increased expression of ENO2 protein CTD PMID:22613180 cadmium dichloride increases expression ISO RGD:733932 6480464 Cadmium Chloride results in increased expression of ENO2 mRNA, Cadmium Chloride results in increased expression of ENO2 protein CTD PMID:24527689 , PMID:25596134 caffeine affects phosphorylation ISO RGD:733932 6480464 Caffeine affects the phosphorylation of ENO2 protein CTD PMID:35688186 cannabidiol multiple interactions EXP 6480464 Cannabidiol inhibits the reaction [3-nitropropionic acid results in decreased expression of ENO2 mRNA] CTD PMID:17672854 capsaicin multiple interactions ISO RGD:10527 6480464 Capsaicin inhibits the reaction [Benzo(a)pyrene results in increased expression of ENO2 protein] CTD PMID:19449198 carbon nanotube affects expression ISO RGD:733932 6480464 Nanotubes, Carbon affects the expression of ENO2 protein CTD PMID:22001959 cefaloridine increases expression EXP 6480464 Cephaloridine results in increased expression of ENO2 mRNA CTD PMID:18500788 chloroacetaldehyde increases expression ISO RGD:733932 6480464 chloroacetaldehyde results in increased expression of ENO2 mRNA CTD PMID:25596134 chloroquine multiple interactions EXP 6480464 Chloroquine inhibits the reaction [Sirolimus results in increased expression of ENO2 protein] CTD PMID:26676567 chlorpromazine increases expression EXP 6480464 Chlorpromazine results in increased expression of ENO2 mRNA CTD PMID:25596134 chromium(6+) increases expression ISO RGD:733932 6480464 chromium hexavalent ion results in increased expression of ENO2 mRNA CTD PMID:17382205 cidofovir anhydrous increases expression ISO RGD:733932 6480464 Cidofovir results in increased expression of ENO2 mRNA CTD PMID:25596134 cisplatin affects expression ISO RGD:733932 6480464 Cisplatin affects the expression of ENO2 mRNA CTD PMID:23300844 cisplatin increases expression ISO RGD:733932 6480464 Cisplatin results in increased expression of ENO2 mRNA CTD PMID:25596134 , PMID:33545341 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of ENO2 mRNA CTD PMID:22023808 clodronic acid increases expression ISO RGD:733932 6480464 Clodronic Acid results in increased expression of ENO2 mRNA CTD PMID:25596134 cobalt atom multiple interactions ISO RGD:733932 6480464 [tungsten carbide binds to Cobalt] which results in increased expression of ENO2 mRNA CTD PMID:20105288 cobalt dichloride multiple interactions ISO RGD:733932 6480464 zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of ENO2 mRNA] CTD PMID:22202117 cobalt dichloride increases expression ISO RGD:10527 6480464 cobaltous chloride results in increased expression of ENO2 protein CTD PMID:16772336 cobalt dichloride increases expression ISO RGD:733932 6480464 cobaltous chloride results in increased expression of ENO2 mRNA CTD PMID:19376846 more ... cobalt(2+) sulfate increases expression ISO RGD:733932 6480464 cobalt sulfate results in increased expression of ENO2 mRNA CTD PMID:19502547 cocaine decreases expression ISO RGD:733932 6480464 Cocaine results in decreased expression of ENO2 mRNA CTD PMID:12629581 cocaine increases expression ISO RGD:733932 6480464 Cocaine results in increased expression of ENO2 protein CTD PMID:17075605 cyclosporin A increases expression ISO RGD:733932 6480464 Cyclosporine results in increased expression of ENO2 mRNA CTD PMID:25562108 , PMID:25596134 cyclosporin A decreases expression ISO RGD:733932 6480464 Cyclosporine results in decreased expression of ENO2 mRNA CTD PMID:27989131 D-glucose increases secretion ISO RGD:733932 6480464 Glucose deficiency results in increased secretion of ENO2 protein CTD PMID:24802182 DAPT multiple interactions ISO RGD:10527 6480464 N-(N-(3, 5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester promotes the reaction [rhodioloside results in increased expression of ENO2 mRNA] CTD PMID:24929042 deguelin decreases secretion ISO RGD:733932 6480464 deguelin results in decreased secretion of ENO2 protein CTD PMID:26884827 deguelin decreases expression ISO RGD:733932 6480464 deguelin results in decreased expression of ENO2 mRNA CTD PMID:33512557 dexamethasone decreases expression ISO RGD:10527 6480464 Dexamethasone results in decreased expression of ENO2 protein CTD PMID:33567340 dexamethasone multiple interactions ISO RGD:733932 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of ENO2 mRNA CTD PMID:28628672 diethylstilbestrol decreases expression ISO RGD:733932 6480464 Diethylstilbestrol results in decreased expression of ENO2 mRNA CTD PMID:15159206 dinophysistoxin 1 decreases expression ISO RGD:733932 6480464 dinophysistoxin 1 results in decreased expression of ENO2 mRNA CTD PMID:28939011 dioxygen multiple interactions ISO RGD:733932 6480464 1-cyclopropyl-4-(4-((5-methyl-3-(3-(4-(trifluoromethoxy)phenyl)-1 more ... CTD PMID:24403227 dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of ENO2 mRNA CTD PMID:33729688 dioxygen increases expression ISO RGD:733932 6480464 Oxygen deficiency results in increased expression of ENO2 mRNA CTD PMID:19502547 more ... dioxygen affects expression ISO RGD:10527 6480464 Oxygen deficiency affects the expression of ENO2 mRNA CTD PMID:17193925 disulfoton increases expression EXP 6480464 Disulfoton results in increased expression of ENO2 mRNA CTD PMID:12935443 diuron increases expression ISO RGD:733932 6480464 Diuron metabolite results in increased expression of ENO2 mRNA CTD PMID:24172598 dorsomorphin multiple interactions ISO RGD:733932 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin affects expression ISO RGD:733932 6480464 Doxorubicin affects the expression of ENO2 protein CTD PMID:29385562 doxorubicin decreases expression ISO RGD:733932 6480464 Doxorubicin results in decreased expression of ENO2 mRNA CTD PMID:29803840 elemental selenium increases expression ISO RGD:733932 6480464 Selenium results in increased expression of ENO2 mRNA CTD PMID:19244175 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of ENO2 mRNA CTD PMID:29391264 entinostat increases expression ISO RGD:733932 6480464 entinostat results in increased expression of ENO2 mRNA CTD PMID:22613180 estriol decreases expression ISO RGD:733932 6480464 Estriol results in decreased expression of ENO2 mRNA CTD PMID:15159206 estrone decreases expression ISO RGD:733932 6480464 Estrone results in decreased expression of ENO2 mRNA CTD PMID:15159206 ethanol decreases expression ISO RGD:733932 6480464 Ethanol results in decreased expression of ENO2 mRNA CTD PMID:23378141 , PMID:28986285 ethanol affects splicing ISO RGD:10527 6480464 Ethanol affects the splicing of ENO2 mRNA CTD PMID:30319688 ferric oxide increases expression ISO RGD:10527 6480464 ferric oxide analog results in increased expression of ENO2 mRNA CTD PMID:25086211 ferric oxide decreases expression ISO RGD:10527 6480464 ferric oxide analog results in decreased expression of ENO2 mRNA CTD PMID:24525745 ferroheme b increases expression ISO RGD:10527 6480464 Heme metabolite results in increased expression of ENO2 mRNA CTD PMID:19191707 folic acid increases expression ISO RGD:10527 6480464 Folic Acid results in increased expression of ENO2 mRNA CTD PMID:25629700 furan increases expression EXP 6480464 furan results in increased expression of ENO2 mRNA CTD PMID:27387713 gallic acid decreases expression ISO RGD:733932 6480464 Gallic Acid results in decreased expression of ENO2 mRNA CTD PMID:34408198 genistein decreases expression ISO RGD:733932 6480464 Genistein results in decreased expression of ENO2 mRNA CTD PMID:15159206 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of ENO2 mRNA CTD PMID:33387578 glucose increases secretion ISO RGD:733932 6480464 Glucose deficiency results in increased secretion of ENO2 protein CTD PMID:24802182 heme b increases expression ISO RGD:10527 6480464 Heme metabolite results in increased expression of ENO2 mRNA CTD PMID:19191707 ifosfamide increases expression ISO RGD:733932 6480464 Ifosfamide results in increased expression of ENO2 mRNA CTD PMID:25596134 indometacin multiple interactions ISO RGD:733932 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of ENO2 mRNA CTD PMID:28628672 ivermectin decreases expression ISO RGD:733932 6480464 Ivermectin results in decreased expression of ENO2 protein CTD PMID:32959892 ketamine decreases expression EXP 6480464 Ketamine results in decreased expression of ENO2 protein CTD PMID:18504422 leflunomide increases expression ISO RGD:733932 6480464 leflunomide results in increased expression of ENO2 mRNA CTD PMID:28988120 maneb multiple interactions ISO RGD:10527 6480464 [Maneb co-treated with Paraquat] results in increased expression of ENO2 protein CTD PMID:23562983 manganese(II) chloride decreases expression ISO RGD:10527 6480464 manganese chloride results in decreased expression of ENO2 protein CTD PMID:24969583 manganese(II) chloride increases expression EXP 6480464 manganese chloride results in increased expression of ENO2 mRNA CTD PMID:22281203 manganese(II) chloride multiple interactions ISO RGD:10527 6480464 Melatonin inhibits the reaction [manganese chloride results in decreased expression of ENO2 protein] CTD PMID:24969583 melatonin multiple interactions ISO RGD:10527 6480464 Melatonin inhibits the reaction [manganese chloride results in decreased expression of ENO2 protein] CTD PMID:24969583 metformin increases expression EXP 6480464 Metformin results in increased expression of ENO2 mRNA CTD PMID:25596134 methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of ENO2 protein CTD PMID:19826936 methotrexate decreases response to substance ISO RGD:733932 6480464 ENO2 mRNA results in decreased susceptibility to Methotrexate CTD PMID:18694510 methyl methanesulfonate increases expression ISO RGD:733932 6480464 Methyl Methanesulfonate results in increased expression of ENO2 mRNA CTD PMID:23649840 methylseleninic acid increases expression ISO RGD:733932 6480464 methylselenic acid results in increased expression of ENO2 mRNA CTD PMID:18548127 mifepristone decreases expression EXP 6480464 Mifepristone results in decreased expression of ENO2 mRNA CTD PMID:25972201 N-acetyl-beta-D-glucosamine increases expression ISO RGD:733932 6480464 Acetylglucosamine results in increased expression of ENO2 mRNA CTD PMID:18047607 N-acetyl-D-glucosamine increases expression ISO RGD:733932 6480464 Acetylglucosamine results in increased expression of ENO2 mRNA CTD PMID:18047607 N-nitrosodimethylamine increases expression ISO RGD:733932 6480464 Dimethylnitrosamine results in increased expression of ENO2 mRNA CTD PMID:17547211 nickel dichloride increases expression ISO RGD:733932 6480464 nickel chloride results in increased expression of ENO2 mRNA CTD PMID:17312168 , PMID:21455298 nickel sulfate increases expression ISO RGD:733932 6480464 nickel sulfate results in increased expression of ENO2 mRNA CTD PMID:17382205 niclosamide increases expression ISO RGD:733932 6480464 Niclosamide results in increased expression of ENO2 mRNA CTD PMID:22576131 Nonylphenol decreases expression ISO RGD:733932 6480464 nonylphenol results in decreased expression of ENO2 mRNA CTD PMID:15159206 ochratoxin A increases expression EXP 6480464 ochratoxin A results in increased expression of ENO2 mRNA CTD PMID:19717638 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of ENO2 mRNA CTD PMID:33387578 paraquat multiple interactions ISO RGD:10527 6480464 [Maneb co-treated with Paraquat] results in increased expression of ENO2 protein CTD PMID:23562983 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of ENO2 protein CTD PMID:24521700 paraquat increases expression EXP 6480464 Paraquat results in increased expression of ENO2 mRNA CTD PMID:18198484 paraquat increases expression ISO RGD:10527 6480464 Paraquat results in increased expression of ENO2 mRNA alternative form CTD PMID:17064354 PCB138 increases expression EXP 6480464 2 more ... CTD PMID:21673325 PCB138 multiple interactions ISO RGD:10527 6480464 [2 more ... CTD PMID:25510870 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:10527 6480464 perfluorooctane sulfonic acid results in decreased expression of ENO2 mRNA CTD PMID:23948355 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:10527 6480464 [perfluorooctane sulfonic acid co-treated with Tretinoin] results in decreased expression of ENO2 mRNA CTD PMID:23948355 perfluorooctanoic acid multiple interactions ISO RGD:10527 6480464 Dietary Fats, Unsaturated promotes the reaction [perfluorooctanoic acid results in increased expression of ENO2 mRNA] CTD PMID:23626681 perfluorooctanoic acid decreases expression ISO RGD:10527 6480464 perfluorooctanoic acid results in decreased expression of ENO2 mRNA CTD PMID:23626681 , PMID:23948355 phenylephrine increases expression EXP 6480464 Phenylephrine results in increased expression of ENO2 mRNA CTD PMID:18158353 phenylmercury acetate decreases expression ISO RGD:733932 6480464 Phenylmercuric Acetate results in decreased expression of ENO2 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:733932 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ENO2 mRNA CTD PMID:27188386 picoxystrobin decreases expression ISO RGD:733932 6480464 picoxystrobin results in decreased expression of ENO2 mRNA CTD PMID:33512557 pirinixic acid multiple interactions ISO RGD:10527 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ENO2 mRNA CTD PMID:19710929 potassium chromate increases expression ISO RGD:733932 6480464 potassium chromate(VI) results in increased expression of ENO2 mRNA CTD PMID:17382205 propanal increases expression ISO RGD:733932 6480464 propionaldehyde results in increased expression of ENO2 mRNA CTD PMID:26079696 rac-lactic acid decreases expression ISO RGD:733932 6480464 Lactic Acid results in decreased expression of ENO2 mRNA CTD PMID:30851411 raloxifene affects expression ISO RGD:733932 6480464 Raloxifene Hydrochloride affects the expression of ENO2 mRNA CTD PMID:14699072 resorcinol increases expression ISO RGD:733932 6480464 resorcinol results in increased expression of ENO2 mRNA CTD PMID:22623647 resveratrol decreases expression ISO RGD:733932 6480464 resveratrol results in decreased expression of ENO2 mRNA CTD PMID:15582268 resveratrol increases expression EXP 6480464 resveratrol results in increased expression of ENO2 protein CTD PMID:24464877 Salidroside increases expression ISO RGD:10527 6480464 rhodioloside results in increased expression of ENO2 mRNA, rhodioloside results in increased expression of ENO2 protein CTD PMID:24929042 Salidroside multiple interactions ISO RGD:10527 6480464 N-(N-(3 more ... CTD PMID:24929042 sarin decreases expression EXP 6480464 Sarin results in decreased expression of ENO2 protein CTD PMID:28973502 SB 431542 multiple interactions ISO RGD:733932 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 selenium atom increases expression ISO RGD:733932 6480464 Selenium results in increased expression of ENO2 mRNA CTD PMID:19244175 silicon dioxide increases expression ISO RGD:733932 6480464 Silicon Dioxide analog results in increased expression of ENO2 mRNA, Silicon Dioxide results in increased expression of ENO2 mRNA CTD PMID:25351596 , PMID:25895662 sirolimus multiple interactions EXP 6480464 3-methyladenine inhibits the reaction [Sirolimus results in increased expression of ENO2 protein], Chloroquine inhibits the reaction [Sirolimus results in increased expression of ENO2 protein] CTD PMID:26676567 sirolimus increases expression EXP 6480464 Sirolimus results in increased expression of ENO2 protein CTD PMID:26676567 sodium arsenate multiple interactions ISO RGD:733932 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of ENO2 mRNA CTD PMID:32525701 sodium arsenite multiple interactions ISO RGD:733932 6480464 [sodium arsenite co-treated with monoisoamyl-2, 3-dimercaptosuccinate] results in decreased expression of ENO2 mRNA CTD PMID:19615344 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of ENO2 protein CTD PMID:29459688 sodium arsenite decreases expression ISO RGD:733932 6480464 sodium arsenite results in decreased expression of ENO2 mRNA CTD PMID:19615344 sotorasib multiple interactions ISO RGD:733932 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ENO2 mRNA CTD PMID:36139627 streptozocin multiple interactions ISO RGD:10527 6480464 [Streptozocin co-treated with Dietary Fats] results in decreased expression of ENO2 mRNA, Diethylhexyl Phthalate inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of ENO2 mRNA] CTD PMID:33484791 succimer multiple interactions ISO RGD:10527 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ENO2 mRNA CTD PMID:26378955 sunitinib increases expression ISO RGD:733932 6480464 Sunitinib results in increased expression of ENO2 mRNA CTD PMID:31533062 tebufenpyrad decreases expression ISO RGD:733932 6480464 4-chloro-N-((4-(1, 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in decreased expression of ENO2 mRNA CTD PMID:33512557 temozolomide decreases expression ISO RGD:733932 6480464 Temozolomide results in decreased expression of ENO2 mRNA CTD PMID:31758290 tetrachloromethane decreases expression ISO RGD:10527 6480464 Carbon Tetrachloride results in decreased expression of ENO2 mRNA CTD PMID:17484886 thapsigargin increases expression ISO RGD:733932 6480464 Thapsigargin results in increased expression of ENO2 mRNA CTD PMID:29453283 thimerosal decreases expression ISO RGD:733932 6480464 Thimerosal results in decreased expression of ENO2 mRNA CTD PMID:27188386 thioacetamide increases methylation EXP 6480464 Thioacetamide results in increased methylation of ENO2 promoter CTD PMID:27914986 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of ENO2 mRNA CTD PMID:34492290 trametinib multiple interactions ISO RGD:733932 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ENO2 mRNA CTD PMID:36139627 tremolite asbestos increases expression ISO RGD:10527 6480464 tremolite results in increased expression of ENO2 mRNA CTD PMID:29279043 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of ENO2 mRNA CTD PMID:33387578 trichostatin A decreases expression ISO RGD:733932 6480464 trichostatin A results in decreased expression of ENO2 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A affects expression ISO RGD:733932 6480464 trichostatin A affects the expression of ENO2 mRNA CTD PMID:28542535 trichostatin A multiple interactions ISO RGD:733932 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ENO2 mRNA CTD PMID:27188386 Tungsten carbide multiple interactions ISO RGD:733932 6480464 [tungsten carbide binds to Cobalt] which results in increased expression of ENO2 mRNA CTD PMID:20105288 tunicamycin decreases expression ISO RGD:733932 6480464 Tunicamycin results in decreased expression of ENO2 mRNA CTD PMID:22378314 urethane decreases expression ISO RGD:733932 6480464 Urethane results in decreased expression of ENO2 mRNA CTD PMID:28818685 valproic acid decreases expression ISO RGD:733932 6480464 Valproic Acid results in decreased expression of ENO2 mRNA, Valproic Acid results in decreased expression of ENO2 protein CTD PMID:18599177 more ... valproic acid multiple interactions ISO RGD:733932 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ENO2 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:733932 6480464 Valproic Acid results in increased expression of ENO2 mRNA CTD PMID:29154799 valproic acid affects expression ISO RGD:10527 6480464 Valproic Acid affects the expression of ENO2 mRNA CTD PMID:17292431 valproic acid affects expression ISO RGD:733932 6480464 Valproic Acid affects the expression of ENO2 mRNA CTD PMID:25979313 vandetanib increases expression ISO RGD:733932 6480464 vandetanib results in increased expression of ENO2 mRNA CTD PMID:16052530 vitamin E increases expression ISO RGD:733932 6480464 Vitamin E results in increased expression of ENO2 mRNA CTD PMID:19244175 vorinostat multiple interactions ISO RGD:733932 6480464 [decitabine co-treated with vorinostat] affects the expression of ENO2 mRNA CTD PMID:17330099 vorinostat decreases expression ISO RGD:733932 6480464 vorinostat results in decreased expression of ENO2 mRNA CTD PMID:18769122 WIN 55212-2 decreases expression ISO RGD:733932 6480464 (3R)-((2 more ... CTD PMID:27324222 WIN 55212-2 multiple interactions ISO RGD:733932 6480464 (3R)-((2 more ... CTD PMID:27324222 Yessotoxin increases expression ISO RGD:733932 6480464 yessotoxin analog results in increased expression of ENO2 mRNA CTD PMID:30679557 zinc dichloride multiple interactions ISO RGD:733932 6480464 zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of ENO2 mRNA] CTD PMID:22202117
